Risk of obstructive sleep apnea among Saudis with chronic renal failure on hemodialysis
- PMID: 26664564
- PMCID: PMC4652292
- DOI: 10.4103/1817-1737.164300
Risk of obstructive sleep apnea among Saudis with chronic renal failure on hemodialysis
Abstract
Aim: The prevalence of obstructive sleep apnea (OSA) in end-stage renal disease (ESRD) patients was reported to be 10-fold that in the general population. OSA can worsen the clinical symptoms and cardiovascular complications of ESRD. We aimed to investigate the prevalence of symptoms and risk of OSA among Saudi patients with ESRD.
Settings and design: This multi-center, cross-sectional study was conducted in Jeddah, Saudi Arabia, between June 2012 and September 2013.
Methods: The prevalence of OSA was assessed using the Berlin questionnaire. The presence of daytime sleepiness was evaluated using the Epworth sleepiness scale. Data were also collected on the medical history, clinical, and laboratory findings of participants.
Results: In all, 355 patients (61% male) were enrolled (mean age: 45.5 ± 15.4 years). The overall prevalence of high-risk of OSA was 44.2% (males, 47.3%; females, 44.8%; P = 0.65). The prevalence of excessive daytime sleepiness (EDS) was 74%. Controlling for age, gender and body mass index, multivariate analysis revealed that hypertension and hepatitis C infection were the only comorbidities significantly associated with OSA (odds ratio [OR]: 3.827 and 0.559; confidence interval [CI]: 2.120-6.906 and 0.324-0.964; P < 0.0001 and 0.036, respectively). OSA was also strongly associated with EDS (OR: 3.054; CI: 1.676-5.565; P < 0.0001).
Conclusions: In Saudi Arabia, the risk of OSA is more common in ESRD patients than in the general population. OSA is strongly associated with EDS. Interestingly, a significant negative correlation between OSA and hepatitis C infection was noted, which warrants further investigation.
Keywords: Chronic renal failure; excessive daytime sleepiness; prevalence; risk of obstructive sleep apnea.
Similar articles
-
Symptoms of Daytime Sleepiness and Sleep Apnea in Liver Cirrhosis Patients.Ann Hepatol. 2017 Jul-Aug;16(4):591-598. doi: 10.5604/01.3001.0010.0304. Ann Hepatol. 2017. PMID: 28611264
-
[Risk for sleep apnea syndrome and excessive daily sleepiness in chronic hemodialysis patients].Acta Med Croatica. 2011 Oct;65 Suppl 3:30-5. Acta Med Croatica. 2011. PMID: 23120812 Croatian.
-
Risk of obstructive sleep apnea and excessive daytime sleepiness in hospitalized psychiatric patients.Neuropsychiatr Dis Treat. 2017 Apr 26;13:1193-1200. doi: 10.2147/NDT.S131311. eCollection 2017. Neuropsychiatr Dis Treat. 2017. PMID: 28490881 Free PMC article.
-
Obstructive sleep apnea is a common disorder in the population-a review on the epidemiology of sleep apnea.J Thorac Dis. 2015 Aug;7(8):1311-22. doi: 10.3978/j.issn.2072-1439.2015.06.11. J Thorac Dis. 2015. PMID: 26380759 Free PMC article. Review.
-
Sleep apnea is a manifestation of the metabolic syndrome.Sleep Med Rev. 2005 Jun;9(3):211-24. doi: 10.1016/j.smrv.2005.01.006. Sleep Med Rev. 2005. PMID: 15893251 Review.
Cited by
-
Meta-analysis of the effects of CPAP therapy on estimated glomerular filtration rate in patients with obstructive sleep apnea.Sleep Breath. 2023 Dec;27(6):2155-2163. doi: 10.1007/s11325-023-02811-6. Epub 2023 Mar 20. Sleep Breath. 2023. PMID: 36940015
-
Sleep Quality and Its Affecting Factors among Hemodialysis Patients: A Multicenter Cross-Sectional Study.Healthcare (Basel). 2023 Sep 14;11(18):2536. doi: 10.3390/healthcare11182536. Healthcare (Basel). 2023. PMID: 37761733 Free PMC article.
-
Sleep apnoea syndrome prevalence in chronic kidney disease and end-stage kidney disease patients: a systematic review and meta-analysis.Clin Kidney J. 2023 Nov 14;17(1):sfad179. doi: 10.1093/ckj/sfad179. eCollection 2024 Jan. Clin Kidney J. 2023. PMID: 38186876 Free PMC article.
-
Risk factors of sleep-disordered breathing in haemodialysis patients.PLoS One. 2019 Aug 12;14(8):e0220932. doi: 10.1371/journal.pone.0220932. eCollection 2019. PLoS One. 2019. PMID: 31404113 Free PMC article. Clinical Trial.
References
-
- Sleep-related breathing disorders in adults: Recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep. 1999;22:667–89. - PubMed
-
- Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000;342:1378–84. - PubMed
-
- Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: An observational study. Lancet. 2005;365:1046–53. - PubMed
-
- Mooe T, Franklin KA, Wiklund U, Rabben T, Holmström K. Sleep-disordered breathing and myocardial ischemia in patients with coronary artery disease. Chest. 2000;117:1597–602. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources